Our team has been hard at work parsing out the most important trends and generating meaningful insights across our customer segments for your company’s business needs. Here’s a quick overview of all of the reports and insights we’ve released this summer, which you can dive into here after signing into our client portal.
For further insights and musings on the oncology sector, please also check out our latest articles at https://www.hmpmarketaccessinsights.com/insights. From articles on the Enhancing Oncology Model and IDN pharmacy performance metrics to payer pathways, we are sure to cover a topic that piques your interest!
In the final part of this 3-part podcast series, HMP Executive Vice President Lee Blansett and special guest John Hennessy—health system, provider and oncology strategist—explore emerging models for success in oncology practice economics.
Lee BlansettBispecific antibodies have emerged with great promise, but adoption has been slower than expected. This was a key topic discussed by a panel of 5 experts at the October 2024 Association for Value-Based Cancer Care (AVBCC) conference.
Chris Van DenburgIn part 2 of this 3-part podcast series, HMP Executive Vice President Lee Blansett and special guest John Hennessy—health system, provider and oncology strategist—explore the operational realities of oncology practice economics.
Lee Blansett